One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
TROP2-Directed Antibody-Drug Conjugates in Advanced Non-Small Cell Lung Cancer: A Fading Hope?.
Perol, Maurice MD 1,,
doi : 10.1200/JCO.24.01043
Volume 42(24) pgs. 2839-2944 August 20, 2024
Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic Syndromes.
Cutler, Corey MD, MPH 1,,
doi : 10.1200/JCO.24.00649
Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial.
Einstein, David J. MD 1,2,,; Regan, Meredith M. ScD 2,3,; Stevens, Julia S. PharmD, BCOP 4,; McDermott, David F. MD 1,2; Madan, Ravi A. MD 5,
doi : 10.1200/JCO.24.00279
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
Nowak, Jonathan A. MD, PhD 1,2,3,,; Twombly, Tyler BS 1; Ma, Chao MS 2; Shi, Qian PhD 4,; Haruki, Koichiro MD, PhD 5; Fujiyoshi, Kenji MD, PhD 6; Vayrynen, Juha MD, PhD 7; Zhao, Melissa MD, MS 1,3; Knight, James PhD 8; Mane, Shrikant PhD 8; Shergill, Ardaman MD 9,10,; Kumar, Pankaj MD 11; Couture, Felix MD 12,; Kuebler, Philip MD 13,; Krishnamurthi, Smitha MD 14,; Tan, Benjamin MD 15,; Philip, Philip MD, PhD 16,; O'Reilly, Eileen M. MD 17,; Shields, Anthony F. MD 16,; Ogino, Shuji MD, PhD 1,3,18; Fuchs, Charles S. MD, MPH 19,; Meyerhardt, Jeffrey A. MD, MPH, FASCO 2,3,
doi : 10.1200/JCO.23.01680
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.
Paz-Ares, Luis G. MD, PhD 1,,; Juan-Vidal, Oscar MD 2,; Mountzios, Giannis S. MD, PhD 3,; Felip, Enriqueta MD, PhD 4,; Reinmuth, Niels MD 5,; de Marinis, Filippo MD, PhD 6,; Girard, Nicolas MD, PhD 7,; Patel, Vipul M. MD 8; Takahama, Takayuki MD, PhD 9,; Owen, Scott P. MD 10,; Reznick, Douglas M. MD 11; Badin, Firas B. MD 12,; Cicin, Irfan MD 13,;
doi : 10.1200/JCO.24.00733
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes.
Tentori, Cristina Astrid MD 1,2; Gregorio, Caterina PhD 3,4,5; Robin, Marie MD 6,; Gagelmann, Nico MD 7,; Gurnari, Carmelo MD 8; Ball, Somedeb MD 9; Caballero Berrocal, Juan Carlos MD 10,; Lanino, Luca MD 1,2; D'Amico, Saverio MEng 1; Spreafico, Marta PhD 11; Maggioni, Giulia MD 1,2; Travaglino, Erica BsC 12; Sauta
doi : 10.1200/JCO.23.02175
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Chapman, Judith-Anne W. PhD 1,,; Bayani, Jane PhD 2,3,; SenGupta, Sandip MD 4; Bartlett, John M.S. PhD 5,; Piper, Tammy MSc 5; Quintayo, Mary Anne MSc 2; Virk, Shakeel BSc 6; Goss, Paul E. MD, PhD 7; Ingle, James N. MD 8; Ellis, Matthew J. MD, PhD 9,; Sledge, George W. MD 10,; Budd, G. Thomas MD 11,; Rabaglio, Manuela MD 12; Ansari, Rafat H. MD 13; Tozer, Richard MD 14; D'Souza, David P. MD 15,; Chalchal, Haji MBBS 16; Spadafora, Silvana MD 17,; Stearns, Vered MD 18,; Perez, Edith A. MD 7,19,; Gelmon, Karen A. MD 20,; Whelan, Timothy J. BM, BCh 14,; Elliott, Catherine MSc 6; Shepherd, Lois E. MD 6; Chen, Bingshu E. PhD 6; Taylor, Karen J. PhD 5
doi : 10.1200/JCO.24.00835
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.
Schneider, Bryan P. MD 1,,; Zhao, Fengmin PhD 2,; Ballinger, Tarah J. MD 1,; Garcia, Sofia F. PhD 3; Shen, Fei MD 1; Virani, Shamsuddin MD 4,; Cella, David PhD 3,; Bales, Casey MPH 1,; Jiang, Guanglong MS 1; Hayes, Lisa JD 5,; Miller, Nadia BA 5; Srinivasiah, Jayanthi MD 6; Stringer-Reasor, Erica M. MD 7,; Chitalia, Ami MD 8,; Davis, Andrew A. MD 9,; Makower, Della F. MD 10; Incorvati, Jason MD 11,; Simon, Melissa A. MD 3,; Mitchell, Edith P. MD 12,+,; DeMichele, Angela MD 13,; Miller, Kathy D. MD 1,; Sparano, Joseph A. MD 14,; Wagner, Lynne I. PhD 15,; Wolff, Antonio C. MD 16,
doi : 10.1200/JCO.24.00526
Magnitude and Temporal Variations of Socioeconomic Inequalities in the Quality of Life After Early Breast Cancer: Results From the Multicentric French CANTO Cohort.
Sandoval, Jose Luis MD, PhD, MScPH 1,2,; Franzoi, Maria Alice MD, PhD 3,; di Meglio, Antonio MD, PhD 3,4,; Ferreira, Arlindo R. MD, PhD 5,; Viansone, Alessandro MD 4,; Andre, Fabrice MD, PhD 3,4,; Martin, Anne-Laure PhD 6; Everhard, Sibille PhD 6; Jouannaud, Christelle MD 7,; Fournier, Marion MD 8; Rouanet, Philippe MD, PhD 9; Vanlemmens, Laurence MD 10; Dhaini-Merimeche, Asma MD 11; Sauterey, Baptiste MD 12; Cottu, Paul MD, PhD 13,; Levy, Christelle MD 14,; Stringhini, Silvia PhD 1; Guessous, Idris MD, PhD 1; Vaz-Luis, Ines MD, PhD 3,15,; Menvielle, Gwenn PhD 3,
doi : 10.1200/JCO.23.02099
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
Kawazoe, Akihito MD 1,,; Xu, Rui-Hua MD, PhD 2,; Garcia-Alfonso, Pilar MD 3,; Passhak, Maria MD 4,; Teng, Hao-Wei MD, PhD 5,6,; Shergill, Ardaman MD 7,; Gumus, Mahmut MD 8,; Qvortrup, Camilla MD, PhD 9,; Stintzing, Sebastian MD 10,; Towns, Kathryn MD 11,; Kim, Tae Won MD 12,; Shiu, Kai Keen MD, PhD 13,; Cundom, Juan MD 14
doi : 10.1200/JCO.23.02736
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.
Hamid, Omid MD 1,,; Lewis, Karl D. MD 2,; Weise, Amy DO 3; McKean, Meredith MD, MPH 4,; Papadopoulos, Kyriakos P. MD 5,; Crown, John MD, BCh, BAO, BSc, FRCPI 6,; Kim, Tae Min MD, PhD 7,; Lee, Dae Ho MD, PhD 8,; Thomas, Sajeve S. MD, BCS 9,; Mehnert, Janice MD 10,; Kaczmar, John MD, BA 11,; Lakhani, Nehal J. MD, PhD 12,; Kim, Kevin B. MD 13,; Middleton, Mark R. PhD, FRCP 14,; Rabinowits, Guilherme MD 15,; Spira, Alexander I. MD, PhD, FACP, FASCO 16,; Yushak, Melinda MD, MPH 17,; Mehmi, Inderjit MD 1,; Fang, Fang PhD 18,; Chen, Shuquan PhD 18,; Mani, Jayakumar PhD, MSc, BTech 18,; Jankovic, Vladimir MD 18,; Wang, Fang PhD 18,; Fiaschi, Nathalie PhD 18,; Brennan, Laura PhD 18,; Paccaly, Anne PhD 18,; Masinde, Sheila PhD 18,; Salvati, Mark PhD 18,; Fury, Matthew G. MD, PhD 18,; Kroog, Glenn MD 18,; Lowy, Israel MD, PhD 18,; Gullo, Giuseppe MD 18,
doi : 10.1200/JCO.23.02172
Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?.
Garcia, Jorge A. MD, FACP; Spratt, Daniel E. MD
doi : 10.1200/JCO.24.00210
Reply to J.A. Garcia et al.
Halabi, Susan PhD; Guo, Siyuan PhD; Roy, Akash PhD; Rydzewska, Larysa E. PhD; Godolphin, Peter PhD; Hussain, Maha MD; Tangen, Catherine PhD; Thompson, Ian MD; Xie, Wanling MS; Carducci, Michael A. MD; Morris, Michael J. MD; Smith, Matthew R. MD, PhD; Gravis, Gwenaelle MD; Dearnaley, David P. MD; Verhagen, Paul J. MD; Goto, Takayuki J. MD; James, Nick D. MD, PhD; Buyse, Marc E. PhD; Tierney, Jayne F. PhD; Sweeney, Christopher J. MD
doi : 10.1200/JCO.24.00625
Difference in Restricted Mean Survival Times as a Measure of Effect Size: No Assumption Does Not Mean No Rule.
de Boissieu, Paul MD, PhD; Chevret, Sylvie MD, PhD
doi : 10.1200/JCO.24.00517
Reply to P. de Boissieu et al.
Birtle, Alison MBBS, MRCP, FRCR, MD; Jones, Robert MBChB, PhD; Cafferty, Fay H. PhD; Biscombe, Katie MSc; Hall, Emma PhD
doi : 10.1200/JCO.24.00844
